StockMarketWire.com - Bryan Garnier today reaffirms its neutral investment rating on GlaxoSmithKline PLC [LON:GSK] and cut its price target to 1660p (from 1710p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk